January 11, 2021

Molitch   Bakris

Hemodialysis University 2019    International Society for Hemodialysis Chicago, IL; September 22-23, 2019 PART 6 Glycemic Management in the Patient with CKD Mark Molitch, MD Use of SGLT2 Inhibitors in CKD George Bakris, MD

Nayak   McIntyre   Kuhlmann   Madero   Rosner   Pirklbauer   Dalrymple   Langone   Andreoni   Pecoits-Filho   Mohan

Advances in Chronic Kidney Disease 2020    Renal Research Institute, Los Angeles, CA; January, 2020 PARTS 2-4 Remote monitoring of peritoneal dialysis patients: a time-tested approach K S Nayak, MD Cardio-protective dialysis Christopher McIntyre, MD PD as a treatment option in congestive heart failure Martin Kuhlmann, MD Heat stress and kidney failure Magdalena Madero, MD Kidney care for undocumented immigrants in US Mitch Rosner, MD Dialysis treatment in patients with extreme electrolyte disturbances Markus Pirklbauer, MD AKI-D in the outpatient dialysis clinic Lorien Dalrymple, MD Management of the failed kidney transplant Anthony Langone, MD Concepts and controversies around the new OPTN/UNOS organ allocation schemes Kenneth Andreoni, MD Management of anemia in non-dialysis CKD: quo vadis Roberto Pecoits-Filho, MD Kidney discards and missed opportunities for transplantation Sumit Mohan, MD

Did you miss these recent slide/audio lectures? Hemodialysis University 2019    International Society for Hemodialysis Chicago, IL; September 22-23, 2019 PART 4 What’s New in Anemia Management for Hemodialysis? Jay Wish, MD Hemodialysis University 2019    International Society for Hemodialysis Chicago, IL; September 22-23, 2019 PART 5 Aspirin and Other Anti-platelet Agents and Vascular Access Anil Agarwal, MD Dosing of Advanced Anti-platelet drugs in coronary syndromes in HD pts Anil Agarwal, MD Modeled Daily Absorbable Phosphorus and Protein Catabolic Rate John Daugirdas, MD Advances in Chronic Kidney Disease 2020    Renal Research Institute, Los Angeles, CA; January, 2020 PART 1 Welcome/Program Overview Peter Kotanko, MD High quality PD: how can it be achieved? Issac Teitelbaum, MD Why should Uremic Pruritus (UP) and Restless Legs Syndrome (RLS) be diagnosed and treated? Mark Unruh MD Intradialytic hypotension: mechanisms and outcome Jeroen Kooman, MD Harvard Intensive Review of Nephrology 2018    Boston, MA; August, 2018 PART 9 Poisonings and intoxications. What a Nephrologist now Needs to Know? Timothy B. Erickson MD

HDCN home /about our site / subscribe to key zone / register for free zone
update email address / subscription status / forget your password?